European equities traded in the US as American depositary receipts kicked off the week lower late Monday morning, declining 0.5% to 1,435.36 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by semiconductor company Sequans Communications (SQNS) and biopharmaceutical company Genfit (GNFT), which rose 6.2% and 5.8% respectively. They were followed by biopharmaceutical company DBV Technologies (DBVT) and petroleum refiner Equinor (EQNR), which were up 2% and 1.7% respectively.
The decliners from continental Europe were led by medical device maker Edap TMS (EDAP) and pharmaceutical company Novo Nordisk (NVO), which dropped 4.3% and 2% respectively. They were followed by financial services company Banco Bilbao Vizcaya Argentaria (BBVA) and accommodations booking site trivago (TRVG), which lost 1.5% and 0.9% respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical company Amarin (AMRN) and biotech firm Trinity Biotech (TRIB), which increased 5.3% and 2.8% respectively. They were followed by oil and gas company BP (BP) and biopharmaceutical company Mereo BioPharma Group (MREO), which rose 1% and 0.9% respectively.
The decliners from the UK and Ireland were led by biopharmaceutical company NuCana (NCNA) and cruise line operator Carnival (CUK), which fell 4.7% and 3.3% respectively. They were followed by hospitality company InterContinental Hotels Group (IHG) and biopharmaceutical company Akari Therapeutics (AKTX), which declined 1.9% and 1.5% respectively.
Price: 1.18, Change: +0.07, Percent Change: +6.22
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。